Loading resource…

World Health Organization
The recommendations provide guidance on the management of sickle cell disease in pregnant women, addressing various aspects such as thromboprophylaxis, anticoagulation regimens, and safety profiles of different medications. It emphasizes the importance of weighing the benefits of anticoagulation against potential risks, particularly in the context of pregnancy. The document aims to improve health outcomes for pregnant women with sickle cell disease and their infants.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Rwanda Gynecology and Obstetrics Clinical Protocols and Treatment Guidelines
Same clinical topic · Obstetrics and Gynecology

Essential Maternal and Newborn Clinical Care Guidelines for Uganda
Same clinical topic · Obstetrics and Gynecology

Postabortion Care Guidelines
Same clinical topic · Obstetrics and Gynecology

Obstetric Fistula: Guiding Principles for Clinical Management
Same clinical topic · Obstetrics and Gynecology

Clinical Management of Obstetric and Neonatal Emergencies in Africa
Same clinical topic · Obstetrics and Gynecology

SOCIETY FOR MATERNAL-FETAL MEDICINE SPECIAL STATEMENT: REDUCING THE RISK OF TRANSMITTING INFECTION DURING ULTRASOUND EXAMINATION—UPDATED 2026
Same clinical topic · Obstetrics and Gynecology

WHO/FIGO/ICM NEW RECOMMENDATIONS FOR PPH PREVENTION AND MANAGEMENT
Same clinical topic · Obstetrics and Gynecology

Maternal and Perinatal Death Surveillance and Response Guidelines
Same clinical topic · Obstetrics and Gynecology

A POCKET GUIDE FOR CLINICAL MANAGEMENT OF OBSTETRIC AND NEONATAL EMERGENCIES IN AFRICA
Same clinical topic · Obstetrics and Gynecology